Levels of PAI-1 and outcome after electrical cardioversion for atrial fibrillation.
Tveit
Arnljot
A
Department of Internal Medicine, Asker and Baerum Hospital, Rud, Norway. arnljot.tveit@broadpark.no
Seljeflot
Ingebjørg
I
Grundvold
Irene
I
Abdelnoor
Michael
M
Smith
Pal
P
Arnesen
Harald
H
D000368:Aged; D001281:Atrial Fibrillation / Q000097:blood / Q000628:therapy*; D015992:Body Mass Index; D004554:Electric Countershock; D005260:Female; D006801:Humans; D008297:Male; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism; D008875:Middle Aged; D017395:Plasminogen Activator Inhibitor 1 / Q000097:blood*; D010959:Tissue Plasminogen Activator / Q000097:blood; D016896:Treatment Outcome; D014841:von Willebrand Factor / Q000032:analysis
D017395:Plasminogen Activator Inhibitor 1; D014841:von Willebrand Factor; D010959:Tissue Plasminogen Activator; D020780:Matrix Metalloproteinase 9